Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

IMPORTANCE: Stereotactic body radiotherapy harnesses improvements in technology to allow the completion of a course of external beam radiotherapy treatment for prostate cancer in the span of 4 to 5 treatment sessions. Although mounting short-term data support this approach, long-term outcomes have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishan, Amar U., Dang, Audrey, Katz, Alan J., Mantz, Constantine A., Collins, Sean P., Aghdam, Nima, Chu, Fang-I, Kaplan, Irving D., Appelbaum, Limor, Fuller, Donald B., Meier, Robert M., Loblaw, D. Andrew, Cheung, Patrick, Pham, Huong T., Shaverdian, Narek, Jiang, Naomi, Yuan, Ye, Bagshaw, Hilary, Prionas, Nicolas, Buyyounouski, Mark K., Spratt, Daniel E., Linson, Patrick W., Hong, Robert L., Nickols, Nicholas G., Steinberg, Michael L., Kupelian, Patrick A., King, Christopher R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484596/
https://www.ncbi.nlm.nih.gov/pubmed/30735235
http://dx.doi.org/10.1001/jamanetworkopen.2018.8006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484596/
https://www.ncbi.nlm.nih.gov/pubmed/30735235
http://dx.doi.org/10.1001/jamanetworkopen.2018.8006

Ejemplares similares